ATYR EBITDA Growth
Atyr Pharma Inc · EBITDA Growth
ATYR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported8.44%period ending
ATYR TTM EBITDA YoY % (-65.26% → 8.44%)
Year-over-year change
High-resolution chart · PNG
ATYR ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 8.4353% | |
| -10.2791% | |
| -16.4735% | |
| -19.2768% | |
| -18.0077% | |
| -21.3205% | |
| -30.7411% | |
| -54.1741% | |
| -29.8827% | |
| -19.0444% | |
| -9.1826% | |
| 10.9513% | |
| -7.6771% | |
| -14.7261% | |
| -34.2189% | |
| -55.5345% | |
| -42.1153% | |
| -57.6598% | |
| -122.0553% | |
| -86.1898% | |
| -91.9551% | |
| -71.5533% | |
| 32.2367% | |
| 28.5734% | |
| 37.2442% | |
| 49.7661% | |
| 32.6183% | |
| 41.6379% | |
| 44.3254% | |
| 36.5752% | |
| 30.9226% | |
| 21.7405% | |
| 18.0571% | |
| 19.6886% | |
| 18.5975% | |
| 21.7934% | |
| 13.2964% | |
| -0.421% | |
| -22.0185% | |
| -68.1351% | |
| -87.2501% | |
| -109.9942% | |
| -106.0338% | |
| -65.262% |